YY1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62329999997546E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.71649974421018E-10 |
Normal-vs-Stage2 |
3.935800E-03 |
Normal-vs-Stage3 |
9.564000E-01 |
Normal-vs-Stage4 |
8.066800E-01 |
Stage1-vs-Stage2 |
5.796800E-01 |
Stage1-vs-Stage3 |
3.575600E-04 |
Stage1-vs-Stage4 |
6.784600E-03 |
Stage2-vs-Stage3 |
3.945700E-02 |
Stage2-vs-Stage4 |
6.168300E-02 |
Stage3-vs-Stage4 |
7.894200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.30530000030937E-07 |
Normal-vs-AfricanAmerican |
3.632100E-04 |
Normal-vs-Asian |
8.560600E-01 |
Caucasian-vs-AfricanAmerican |
7.659600E-01 |
Caucasian-vs-Asian |
2.543000E-01 |
AfricanAmerican-vs-Asian |
3.120600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.6493999499545E-09 |
Normal-vs-Female |
1.510780E-01 |
Male-vs-Female |
4.764000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.202720E-04 |
Normal-vs-Extreme_Weight |
4.32939994965409E-09 |
Normal-vs-Obese |
8.999700E-02 |
Normal-vs-Extreme_Obese |
1.679930E-02 |
Normal_Weight-vs-Extreme_Weight |
4.596400E-01 |
Normal_Weight-vs-Obese |
8.357800E-02 |
Normal_Weight-vs-Extreme_Obese |
6.599200E-01 |
Extreme_Weight-vs-Obese |
6.081900E-03 |
Extreme_Weight-vs-Extreme_Obese |
9.564200E-01 |
Obese-vs-Extreme_Obese |
1.806040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.360800E-01 |
Normal-vs-Age(41-60Yrs) |
1.418360E-03 |
Normal-vs-Age(61-80Yrs) |
2.08760009279274E-10 |
Normal-vs-Age(81-100Yrs) |
3.50979999996781E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.574560E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.591900E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.080400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.782020E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.277700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.855200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.41220002358722E-09 |
Normal-VS-Type2 PRCC |
6.35519999999667E-05 |
Normal-VS-KIRP CIMP |
5.223500E-02 |
Normal-VS-Unclassified PRCC |
3.822300E-02 |
Type1 PRCC-VS-Type2 PRCC |
3.054600E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.335800E-03 |
Type1 PRCC-VS-Unclassified PRCC |
1.043630E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.459000E-03 |
Type2 PRCC-VS-Unclassified PRCC |
4.568600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.041040E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.32939999972915E-07 |
Normal-vs-N1 |
7.498300E-02 |
Normal-vs-N2 |
4.301600E-03 |
N0-vs-N1 |
1.189570E-04 |
N0-vs-N2 |
9.550200E-01 |
N1-vs-N2 |
6.407900E-02 |
|
|